CGIX - Cancer Genetics plummets 38% after raising 'bought deal' offering to $3M

October, 29 2020 08:50 AM Cancer Genetics Inc.

Due to demand, Cancer Genetics (CGIX) announces that the underwriter has agreed to increase the size of its previous public offering of 1,363,637 common shares (from ~909.1K) at $2.20/share, for expected gross proceeds of ~$3M.Underwriter's over-allotment is an additional 204,545 shares. Net proceeds will be used to fund working capital and other general corporate purposes.H.C. Wainwright & Co. is acting as the sole book-running manager.Closing date is November 2.Shares down 38% premarket.

For further details see:

Cancer Genetics plummets 38% after raising 'bought deal' offering to $3M

Company Name:	Cancer Genetics Inc.
Stock Symbol:	CGIX
Market:	NASDAQ

Twitter